| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/22/2001 | US6235725 Methods and compositions for the prevention of tolerance to medications |
| 05/22/2001 | US6235724 Injections containing lipid a analogues and process for the preparation thereof |
| 05/22/2001 | US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression |
| 05/22/2001 | US6235721 Oxidation resistance |
| 05/22/2001 | US6235720 Acid-functionalized saccharide polymers |
| 05/22/2001 | US6235707 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 05/22/2001 | US6235702 Aqueous nacreous lustre concentrate |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235523 Vector having nucleic acid encoding a human papillomavirus-16 e7 antigen lacking the rb protein binding site and operably linked to a cytomegalo virus promoter; vaccines |
| 05/22/2001 | US6235474 Detecting genetic disorders in humans; obtaining wild type sample and screening sample for adjustments in genetic map, an adjustment in genetic map is indicative of genetic disorders |
| 05/22/2001 | US6235315 Solution of lycopene, solvent and emulsifier, mixing and removal of solvent to form dry powder |
| 05/22/2001 | US6235314 Analgesic, anti-inflammatory and skeletal muscle relaxant compositions |
| 05/22/2001 | US6235311 Pharmaceutical composition containing a combination of a statin and aspirin and method |
| 05/22/2001 | US6235305 Drugs as enzyme inhibitors, polysaccharide polymer supports and bonds noncleavable by digestion |
| 05/22/2001 | US6235294 Flavonoide esters and their use notably in cosmetics |
| 05/22/2001 | US6235291 Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
| 05/22/2001 | US6235287 Extract of curcuma amada plant and a compound selected from ocimene, dihydro-ocimene, piene/a-/, curcumene-alpha and beta, linalool, cuminyl alcohol, keto-alchol, turmerone, linalyl acetate, ssfrole, carene-3, myrcene, cineol, limonene |
| 05/22/2001 | US6235285 An isolated polypeptide comprising a heterologous amino acid sequence fused to specific polynucleotide sequence |
| 05/22/2001 | US6235266 Dinucleotides useful for the treatment of lung disease |
| 05/22/2001 | US6235030 Spine distraction implant |
| 05/22/2001 | US6233841 Dehydration plant |
| 05/22/2001 | CA2217006C Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 05/22/2001 | CA2216787C 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants |
| 05/22/2001 | CA2031937C Isomers of 1-azabicyclo¬2.2.2|oct-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboxylate |
| 05/22/2001 | CA2013380C Selective adenosine receptor agents |
| 05/22/2001 | CA2012208C Method of treating periodontitis |
| 05/17/2001 | WO2001035106A2 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | WO2001035102A2 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | WO2001034843A1 Lentiviral vector transduction of hematopoietic stem cells |
| 05/17/2001 | WO2001034827A1 Antisense modulation of rank expression |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034769A2 24 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034633A2 Methods for treatment of human huntington's disease and methods of screening for active agents |
| 05/17/2001 | WO2001034631A2 PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034626A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034617A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 05/17/2001 | WO2001034615A1 Phospholipids of hydroxyeicosatetraenoic acid-like derivatives |
| 05/17/2001 | WO2001034614A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 05/17/2001 | WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/17/2001 | WO2001034608A1 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
| 05/17/2001 | WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | WO2001034606A1 Pharmaceutically active isoindoline derivatives |
| 05/17/2001 | WO2001034605A1 SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS |
| 05/17/2001 | WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same |
| 05/17/2001 | WO2001034603A2 Bicyclic and tricyclic heteroaromatic compounds |
| 05/17/2001 | WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | WO2001034600A1 Protease inhibitors |
| 05/17/2001 | WO2001034599A1 Protease inhibitors |
| 05/17/2001 | WO2001034598A1 [(indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
| 05/17/2001 | WO2001034597A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
| 05/17/2001 | WO2001034595A1 Alkali metal salts of quinolinecarboxylic acid derivatives and process for purifying quinoline-carboxylic acid derivatives by using the salts |
| 05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/17/2001 | WO2001034586A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | WO2001034585A1 Semicarbazone derivatives and their use as thrombopoietin mimetics |
| 05/17/2001 | WO2001034583A1 Antifungal sordaricin derivatives |
| 05/17/2001 | WO2001034582A2 Sordaricin derivatives having antifungal activity |
| 05/17/2001 | WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists |
| 05/17/2001 | WO2001034579A1 Alkoxyiminoalkanoic acid derivatives |
| 05/17/2001 | WO2001034577A1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 05/17/2001 | WO2001034574A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 05/17/2001 | WO2001034572A2 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors |
| 05/17/2001 | WO2001034571A1 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 05/17/2001 | WO2001034570A1 Nitrogenous heterocycle derivatives |
| 05/17/2001 | WO2001034569A1 Pancreatitis remedies |
| 05/17/2001 | WO2001034567A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 05/17/2001 | WO2001034566A2 Protease inhibitors |
| 05/17/2001 | WO2001034565A2 Protease inhibitors |
| 05/17/2001 | WO2001034562A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 05/17/2001 | WO2001034554A1 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 05/17/2001 | WO2001034552A2 Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders |
| 05/17/2001 | WO2001034551A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 05/17/2001 | WO2001034549A1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 05/17/2001 | WO2001034548A2 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use |
| 05/17/2001 | WO2001034547A2 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
| 05/17/2001 | WO2001034546A2 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye |
| 05/17/2001 | WO2001034227A1 SIMPLIFIED ADMINISTRATION OF α-LIPOIC ACID OR DERIVATIVES THEREOF |
| 05/17/2001 | WO2001034225A2 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 05/17/2001 | WO2001034208A1 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 05/17/2001 | WO2001034203A1 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 05/17/2001 | WO2001034202A2 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 05/17/2001 | WO2001034201A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 05/17/2001 | WO2001034200A1 Body weight gain inhibitors |
| 05/17/2001 | WO2001034183A2 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
| 05/17/2001 | WO2001034180A2 Interferon gamma for the treatment of asthma |
| 05/17/2001 | WO2001034177A2 Method of treating a viral infection using antagonists of macrophage colony stimulating factor |
| 05/17/2001 | WO2001034176A1 A method and composition for treating prostate cancer |
| 05/17/2001 | WO2001034174A2 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 05/17/2001 | WO2001034172A2 Methods and compositions for treating reward deficiency syndrome |